These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 27354762)

  • 21. A Post-Acute Ocular Tolerability Comparison of Topical Reproxalap 0.25% and Lifitegrast 5% in Patients with Dry Eye Disease.
    McMullin D; Clark D; Cavanagh B; Karpecki P; Brady TC
    Clin Ophthalmol; 2021; 15():3889-3900. PubMed ID: 34588761
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ICAM-1 expression predisposes ocular tissues to immune-based inflammation in dry eye patients and Sjögrens syndrome-like MRL/lpr mice.
    Gao J; Morgan G; Tieu D; Schwalb TA; Luo JY; Wheeler LA; Stern ME
    Exp Eye Res; 2004 Apr; 78(4):823-35. PubMed ID: 15037117
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dry eye syndrome: developments and lifitegrast in perspective.
    Lollett IV; Galor A
    Clin Ophthalmol; 2018; 12():125-139. PubMed ID: 29391773
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monoclonal antibodies against ICAM-1 (CD54) and LFA-1 (CD11a/CD18) inhibit experimental autoimmune uveitis.
    Whitcup SM; DeBarge LR; Caspi RR; Harning R; Nussenblatt RB; Chan CC
    Clin Immunol Immunopathol; 1993 May; 67(2):143-50. PubMed ID: 8100190
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective Pharmacologic Therapies for Dry Eye Disease Treatment: Efficacy, Tolerability, and Safety Data Review from Preclinical Studies and Pivotal Trials.
    Shen Lee B; Toyos M; Karpecki P; Schiffbauer J; Sheppard J
    Ophthalmol Ther; 2022 Aug; 11(4):1333-1369. PubMed ID: 35608780
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Real-World Experience with Lifitegrast Ophthalmic Solution (Xiidra
    Hovanesian JA; Nichols KK; Jackson M; Katz J; Chan A; Glassberg MB; Sloesen B; Korves C; Nguyen C; Syntosi A
    Clin Ophthalmol; 2021; 15():1041-1054. PubMed ID: 33727786
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Use of Conjunctival Staining to Measure Ocular Surface Inflammation in Patients With Dry Eye.
    Yang S; Lee HJ; Kim DY; Shin S; Barabino S; Chung SH
    Cornea; 2019 Jun; 38(6):698-705. PubMed ID: 30844839
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A specific chiral HPLC method for lifitegrast and determination of enantiomeric impurity in drug substance, ophthalmic product and stressed samples.
    Uğur M; Bellur Atici E; Ozkan SA
    J Pharm Biomed Anal; 2024 May; 242():116039. PubMed ID: 38387128
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Study design and baseline findings from the progression of ocular findings (PROOF) natural history study of dry eye.
    McDonnell PJ; Pflugfelder SC; Stern ME; Hardten DR; Conway T; Villanueva L; Hollander DA
    BMC Ophthalmol; 2017 Dec; 17(1):265. PubMed ID: 29284427
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lymphocyte adhesion and transendothelial migration in the central nervous system: the role of LFA-1, ICAM-1, VLA-4 and VCAM-1. off.
    Greenwood J; Wang Y; Calder VL
    Immunology; 1995 Nov; 86(3):408-15. PubMed ID: 8550078
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of intercellular adhesion molecule 1 (ICAM-1) expression on the human mast-cell line (HMC)-1 by inflammatory mediators.
    Wedi B; Elsner J; Czech W; Butterfield JH; Kapp A
    Allergy; 1996 Oct; 51(10):676-84. PubMed ID: 8904994
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlations between tear cytokines, chemokines, and soluble receptors and clinical severity of dry eye disease.
    Na KS; Mok JW; Kim JY; Rho CR; Joo CK
    Invest Ophthalmol Vis Sci; 2012 Aug; 53(9):5443-50. PubMed ID: 22789923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. T lymphocyte adhesion to human synovial fibroblasts. Role of cytokines and the interaction between intercellular adhesion molecule 1 and CD11a/CD18.
    Krzesicki RF; Fleming WE; Winterrowd GE; Hatfield CA; Sanders ME; Chin JE
    Arthritis Rheum; 1991 Oct; 34(10):1245-53. PubMed ID: 1681812
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Competition between lymphocyte function-associated antigen 1 (CD11a/CD18) and Mac-1 (CD11b/CD18) for binding to intercellular adhesion molecule-1 (CD54).
    Lub M; van Kooyk Y; Figdor CG
    J Leukoc Biol; 1996 May; 59(5):648-55. PubMed ID: 8656049
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of RCI001 as a therapeutic candidate of dry eye disease in a modified mixed dry eye model.
    Jung YH; Ku YA; Moon J; Kim S; Ryu JS; Yoon CH; Chung MH; Kim YH; Kim MK; Kim DH
    Eye Vis (Lond); 2024 Jun; 11(1):19. PubMed ID: 38822444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of LFA-1 (CD11a/CD18) cytoplasmic domains in binding to intercellular adhesion molecule-1 (CD54) and in postreceptor cell spreading.
    Pyszniak AM; Carpenito C; Takei F
    Exp Cell Res; 1997 May; 233(1):78-87. PubMed ID: 9184078
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy, safety, and tolerability of lifitegrast 5% eye drops: A randomized, double-blind, active-controlled trial in Indian patients with dry eye disease.
    Sharma N; Basu S; Shetty R; Kumar P; Mondal A; Babu PS; Srivastava R; Pande RA; Karat S; Desai HP; Manjula S; Kumar M K
    Indian J Ophthalmol; 2024 Aug; ():. PubMed ID: 39141509
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ocular Distribution and Pharmacokinetics of Lifitegrast in Pigmented Rabbits and Mass Balance in Beagle Dogs.
    Chung JK; Spencer E; Hunt M; McCauley T; Welty D
    J Ocul Pharmacol Ther; 2018; 34(1-2):224-232. PubMed ID: 29267138
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The influence of benign essential blepharospasm on dry eye disease and ocular inflammation.
    Lu R; Huang R; Li K; Zhang X; Yang H; Quan Y; Li Q
    Am J Ophthalmol; 2014 Mar; 157(3):591-7.e1-2. PubMed ID: 24269849
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of CD11a/CD18-CD54 interactions in human T cell-dependent B cell activation.
    Tohma S; Hirohata S; Lipsky PE
    J Immunol; 1991 Jan; 146(2):492-9. PubMed ID: 1670945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.